References
- Wood PL, Khan MA, Moskal JR. Mechanism of action of the disease-modifying anti-arthritic thiol agents D-penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes. Eur J Pharmacol. 2008;580(1–2):48–54.
- Pasero G, Pellegrini P, Ambanelli U, et al. Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis. Arthritis Rheum. 1982;25(8):923–929.
- Amor B, Mery C, Gery AD. Tiopronin (N-[2-mercaptopropionyl] glycine) in rheumatoid arthritis. Arthritis Rheum. 1982;25(6):698–703.
- Jaffe IA. Adverse effects profile of sulfhydryl compounds in man. Am J Med. 1986;80(3):471–476.
- Czlonkowska A, Litwin T. Wilson disease – currently used anticopper therapy. Handb Clin Neurol. 2017;142:181–191.
- Fjellstedt E, Denneberg T, Jeppsson J-O, et al. Cystine analyses of separate day and night urine as a basis for the management of patients with homozygous cystinuria. Urol Res. 2001;29(5):303–310.
- Joly D, Rieu P, Mejean A, et al. Treatment of cystinuria. Pediatr Nephrol. 1999;13(9):945–950.
- Okumura S, Toshioka N, Asakura S, et al. Studies on the oxidation-reduction potentials of 2-mercaptopropionylglycine and penicillamine using thiol-disulfide exchange reactions with cysteine and glutathione. Yakugaku Zasshi. 1974;94(6):655–659.
- Wood PL, Khan MA, Moskal JR. Cellular thiol pools are responsible for sequestration of cytotoxic reactive aldehydes: central role of free cysteine and cysteamine. Brain Res. 2007;1158:158–163.
- Castañeda-Arriaga R, Vivier-Bunge A, Raul Alvarez-Idaboy J. Primary antioxidant and metal-binding effects of tiopronin: a theoretical investigation of its action mechanism. Comput Theor Chem. 2016;1077:48–57.
- Zhang JG, Lindup WE. Tiopronin protects against the nephrotoxicity of cisplatin in rat renal cortical slices in vitro. Toxicol Appl Pharmacol. 1996;141(2):425–433.
- Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Med J. 2004;45(5):776–788.
- Devi PU, Saharan BR. Chemical protection of mouse spermatocytes against gamma-rays with 2-mercaptopropionylglycine. Experientia. 1978;34(1):91–92.
- Date M-o, Morita T, Yamashita N, et al. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol. 2002;39(5):907–912.
- Abdelkader H, Alany RG, Pierscionek B. Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens. J Pharm Pharmacol. 2015;67(4):537–550.
- Peng Y-S, Zhang J, Zhao W-J, et al. Inhibitory effect of tiopronin on hydrogen dioxide induced cataract in rabbit. Yanke Xinjinzhan. 2009;29(2):114–117.
- Kobayashi S, Kasuya M, Ishii Y, et al. Effects of 2-mercaptopropionylglycine on the development of X-ray-induced cataract in rats. Curr Eye Res. 1992;11(11):1099–1103.
- Ichikawa H, Imaizumi K, Tazawa Y, et al. Effect of tiopronin on senile cataracts. A double-blind clinical study. Ophthalmologica. 1980;180(5):293–298.
- Nishigori H, Hayashi R, Lee JW, et al. Effect of MPG on glucocorticoid-induced cataract formation in developing chick embryo. Invest Ophthalmol Vis Sci. 1984;25(9):1051–1055.
- Jiang T-Y, Sun C-S, Shen X, et al. Development of a poloxamer analogs/bioadhesive polymers-based in situ gelling ophthalmic delivery system for tiopronin. J Appl Polym Sci. 2009;114(2):775–783.
- Kuck JF Jr., Kuck KD. The Emory mouse cataract: the effects on cataractogenesis of alpha-tocopherol, penicillamine, triethylenetetramine, and mercaptopropionylglycine. J Ocul Pharmacol. 1988;4(3):243–251.
- Olsson B, Johansson M, Gabrielsson J, et al. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol. 1988;34(1):77–82.
- Carlsson MS, Denneberg T, Emanuelsson BM, et al. Pharmacokinetics of oral tiopronin. Eur J Clin Pharmacol. 1993;45(1):79–84.
- Beltz J, Pfaff A, Ercal N. Simultaneous determination of tiopronin and its primary metabolite in plasma and ocular tissues by HPLC. Biomed Chromatogr. 2019;33(2):e4375.
- Alia M, Ramos S, Mateos R, et al. Response of the antioxidant defense system to tert-butyl hydroperoxide and hydrogen peroxide in a human hepatoma cell line (HepG2). J Biochem Mol Toxicol. 2005;19(2):119–128.
- Unger RE, Pohl C, Hermanns I, et al. Cell culture systems for studying biomaterial interactions with biological barriers. Methods of analysis. In: Ducheyne P, Healy K, Hutmacher DW, et al., editors. Vol. 1, Comprehensive biomaterials. Amsterdam: Elsevier; 2011.
- Ehrhardt C, Laue M, Kim K-J. In vitro models of the alveolar epithelial barrier. In: Ehrhardt C, Kim K-J, editors. Drug absorption studies: in situ, in vitro and in silico models. Biotechnology: pharmaceutical aspects. Boston, MA: Springer; 2008. p. 258–282.
- Hsu HT, Tseng YT, Wong WJ, et al. Resveratrol prevents nanoparticles-induced inflammation and oxidative stress via downregulation of PKC-alpha and NADPH oxidase in lung epithelial A549 cells. BMC Complement Altern Med. 2018;18(1):211.
- Buckley ST, Kim K-J, Ehrhardt C. In vitro cell culture models for evaluating controlled release pulmonary drug delivery. In: Smyth HDC, Hickey AJ, editors. Controlled pulmonary drug delivery. Advances in delivery science and technology. New York: Springer-Verlag; 2011. p. 417–442.
- Constant S, Wiszniewski L, Huang S. The use of in vitro 3D cell models of human airway epithelia (MucilAir(TM)) in inhalation technology. In: Haycock JW, Ahluwalia A, Wilkinson JM, editors. Cellular in vitro testing: methods and protocols. Boca Raton, FL: CRC Press, Taylor & Francis Group; 2014. p. 15–28.
- Walther UI, Stets R. Glucocorticoid pretreatment increases toxicity due to peroxides in alveolar epithelial-like cell lines. Toxicology. 2009;256(1–2):48–52.
- Dierickx PJ, Nuffel GV, Alvarez I. Glutathione protection against hydrogen peroxide, tert-butyl hydroperoxide and diamide cytotoxicity in rat hepatoma-derived Fa32 cells. Hum Exp Toxicol. 1999;18(10):627–633.
- Pryor W. Oxy-radicals and related and reactions. Annu Rev Physiol. 1986;48:657–667.
- Altman SA, Zastawny TH, Randers L, et al. Tert-butyl hydroperoxide-mediated DNA base damage in cultured mammalian cells. Mutat Res. 1994;306(1):35–44.
- Ates B, Ercal BC, Manda K, et al. Determination of glutathione disulfide levels in biological samples using thiol-disulfide exchanging agent, dithiothreitol. Biomed Chromatogr. 2009;23(2):119–123.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
- Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med. 1999;27(5–6):612–616.
- Wojtala A, Bonora M, Malinska D, et al. Methods to monitor ROS production by fluorescence microscopy and fluorometry. Meth Enzymol. 2014;542:243–262.
- Baker MA, He S. Elaboration of cellular DNA breaks by hydroperoxides. Free Radic Biol Med. 1991;11(6):563–572.
- Vistica DT, Skehan P, Scudiero D, et al. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 1991;51(10):2515–2520.
- Zhang Y, Chen X, Gueydan C, et al. Plasma membrane changes during programmed cell deaths. Cell Res. 2018;28(1):9–21.
- Wlodkowic D, Telford W, Skommer J, et al. Apoptosis and beyond: cytometry in studies of programmed cell death. Methods Cell Biol. 2011;103:55–98.
- Gutteridge JMC, Halliwell B. Free Radicals in Biology and Medicine. New York: Oxford University Press; 2015.
- Park J, Lee J, Choi C. Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers. PLoS One. 2011;6(8):e23211.
- Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87(1):99–163.